Humans can metabolize an extremely wide range of potentially harmful foreign hydrophobic compounds including many drugs, environmental pollutants and chemical carcinogens. This ability is mainly due to the action of cytochromes 1'-450. These proteins constitute a large superfamily that has been classified into several families, the largest of which (P45011) has been further divided into seven subfamilies Variations in the structure or expression of cytochrome 1'-450 genes are thought to be responsible for many of the known inherited variations in the metabolism of therapeutic drugs [2] . The best understood example is that of debrisoquine hydroxylation, in which the poor metabolizer phenotype is due to mutations that cause abnormal RNA rocessing, resulting in the production of an unstable mRNA p. 31. In addition to being subject to genetic variation, the expression of many cytochrome P-450 genes is influenced by environmental factors. Determination of the level of expression of cytochrome P-450 genes in human tissues will contribute greatly to our understanding of the molecular basis of interindividual variations in foreign compound metabolism. Few human cytochromes f-450 have been purified to homogeneity.
However, cDNA clones for many different cytochromes 1'-450 have been isolated by ourselves [4-81 and by other groups (reviewed in [9] ), and these can be used to measure the expression of the corresponding genes at the mRNA level.
Northern-blot hybridization with cDNA probes is often not specific enough to distinguish between closely related cytochrome P-450 mRNAs. Synthetic oligonucleotides, although highly specific, lack the sensitivity required for the quantification of low abundance mRNAs. To overcome these problems we have used a technique, based on RNAase protection [lo], which is highly specific, and can detect as few as 0.05 copies of mRNA per cell. A 32P-labelled 'antisense' RNA is hybridized in solution to total tissue RNA. Probe not protected by hybridization to its complementary mRNA is digested by RNAase. Protected probe is electrophoresed through a denaturing polyacrylamide gel, detected by autoradiography and quantified by scanning densitometry. Comparison with a standard curve of undigested radiolabelled probe permits the absolute quantification of the corresponding mRNA. Assays of known amounts of the mRNA, produced by transcription of a cDNA clone in vitro, confirmed the accuracy of the method.
We have used this technique to measure the expression of several cytochrome P-450 genes in over 20 human livers. The P450IA2 gene displays a 30-fold interindividual variation in expression (from 0.2 to 6 mRNA molecules/cell) (Fig. la) . A similar variation is found for P450IIC (1-30 mRNAs/cell). Other cytochrome P-450 genes exhibit variations in expression ranging from 1 0-fold (0.2-2 mRNAs/cell) in the case of P4501IB, to 1000-fold (0.05-50 mRNAs/cell) for P450IIA. In contrast, the expression of the cytochrome P-450 reductase gene [ l l ] varies by only 3-fold (1-3 mRNAs/cell) between different individuals (Fig. 1 b) .
BIOCHEMICAL SOClETY TRANSACTIONS
None of the cytochrome P-450 genes examined is coordinately regulated. The expression of some of them appears to be confined to the liver, whereas the cytochrome P-450 reductase gene is not subject to tissue-specific regulation.
Our results demonstrate considerable interindividual variation in the level of expression of many cytochrome P-450 genes and this may have important implications for a person's ability to metabolize drugs and carcinogens. Many of the livers we have analysed have been phenotyped with respect to foreign compound metabolism. Therefore, it may be possible to establish correlations between the level of expression of individual cytochrome P-450 genes and particular metabolic activities, thus providing insights into the biological role of the gene products.
